In this issue: Mel Chancey joins us for a conversation on second chances, preventive care, and the pharmacist’s role in what comes next.

We also explore how personalization became pharmacy’s best business model in Made to Order, break down The GLP 1 Showdown from TrumpRx and compounding crackdowns to the new era of drug pricing, and look at The Appeal Advantage, including how PBM reform laws can turn into recovered revenue.

Plus, we examine why every pharmacy should be prescribing birth control, and spotlight The Pharmacy Top 50 Awards 2025.

Weekly conversations with pharmacy leaders, strategy, operations, and what’s next.

Fast, news-driven updates on policy, industry shifts, and what matters right now.